Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients.
Pihlstrøm HK, Ueland T, Michelsen AE, Aukrust P, Gatti F, Hammarström C, Kasprzycka M, Wang J, Haraldsen G, Mjøen G, Dahle DO, Midtvedt K, Eide IA, Hartmann A, Holdaas H. Pihlstrøm HK, et al. Among authors: haraldsen g. PLoS One. 2020 Dec 16;15(12):e0243759. doi: 10.1371/journal.pone.0243759. eCollection 2020. PLoS One. 2020. PMID: 33326471 Free PMC article.
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation.
Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE. Fiane AE, et al. Among authors: haraldsen g. Eur Heart J. 2005 Aug;26(16):1660-5. doi: 10.1093/eurheartj/ehi198. Epub 2005 Apr 8. Eur Heart J. 2005. PMID: 15821010
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins.
Breland UM, Halvorsen B, Hol J, Øie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Frøland SS, Haraldsen G, Gullestad L, Damås JK, Hansson GK, Aukrust P. Breland UM, et al. Among authors: haraldsen g. Arterioscler Thromb Vasc Biol. 2008 May;28(5):1005-11. doi: 10.1161/ATVBAHA.108.162305. Epub 2008 Feb 14. Arterioscler Thromb Vasc Biol. 2008. PMID: 18276907
The alarmin IL-33 is a notch target in quiescent endothelial cells.
Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, Udalova IA, Midwood KS, Kasprzycka M, Haraldsen G. Sundlisaeter E, et al. Among authors: haraldsen g. Am J Pathol. 2012 Sep;181(3):1099-111. doi: 10.1016/j.ajpath.2012.06.003. Epub 2012 Jul 16. Am J Pathol. 2012. PMID: 22809957
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells.
Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J. Pollheimer J, et al. Among authors: haraldsen g. Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):e47-55. doi: 10.1161/ATVBAHA.112.253427. Epub 2012 Nov 15. Arterioscler Thromb Vasc Biol. 2013. PMID: 23162017
Tenascins in fibrotic disorders-from bench to bedside.
Kasprzycka M, Hammarström C, Haraldsen G. Kasprzycka M, et al. Among authors: haraldsen g. Cell Adh Migr. 2015;9(1-2):83-9. doi: 10.4161/19336918.2014.994901. Cell Adh Migr. 2015. PMID: 25793575 Free PMC article. Review.
92 results